Effect of Simvastatin as Pulpotomy Agent in Cariously Exposed Permanent Molars
Study Details
Study Description
Brief Summary
The study will compare the outcome of complete pulpotomy in mature permanent mandibular molars with deep carious lesions by using Mineral Trioxide Aggregate and Simvastatin -alpha tricalcium phosphate as medicament agent
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
After a thorough history, clinical and radiographic examination with all eligibility confirmation, written informed consent will be taken from the patient after explaining the procedure, its associated risks and benefits. Clinical diagnosis of reversible pulpitis will be established. Complete pulpotomy will be done in both groups. Mineral Trioxide Aggregate and Simvastatin -alpha tricalcium phosphate will be used as pulpotomy agents. Pain analysis will be carried out preoperatively and postoperatively at every 6 hours for 1 day and then every 24 hours till 7 days after the intervention. All the subjects will be followed up for evaluation of clinical and radiographic success at 3, 6 months and 1 year.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Complete Pulpotomy using mineral trioxide aggregate Twenty-eight patients with curiously exposed permanent molars will be treated with complete pulpotomy by using Mineral Trioxide Aggregate. |
Procedure: Complete Pulpotomy using Mineral Trioxide Aggregate
Inflammed coronal pulp tissue will be removed till the canal orifices and mineral trioxide aggregate placed over the amputated pulp stump.
|
| Active Comparator: Complete Pulpotomy using Simvastatin-alphatricalcium phosphate Twenty-eight patients with curiously exposed permanent molars will be treated with complete pulpotomy by using Simvastatin -alphatricalcium phospahte. |
Procedure: Complete Pulpotomy using Simvastain -alphatricalcium phosphate
Inflammed coronal pulp tissue will be removed till the canal orifices and Simvastatin -alpha tricalcium phosphate placed over the amputated pulp stump.
|
Outcome Measures
Primary Outcome Measures
- Clinical success [Baseline to 12 months]
criteria for successful clinical outcome will be absence of clinical sign and symtoms which include Absence of tenderness to percussion,tooth mobility of grade 1 or less.Absence of associated soft tissue swelling or tenderness to palpation.
Secondary Outcome Measures
- Pain analysis [Baseline to 7 days]
Assess the incidence and intensity of pain postoperatively at every 6 hours to 1 day till 7d ays using Visual Analogue scale.Pain intensity will be noted as no pain (0-4mm), mild pain (5-44), moderate pain (45-74mm) and severe pain (75-100mm) on the scale of 0-100mm
- Radiographic success [Baseline to 12 months]
Radiographic success will be evaluated by change in periapical index (PAI) scores. PAI score 1: Normal periapical structure PAI score 2: Small changes in bone structure PAI score 3: Changes in bone structure with some mineral loss PAI score 4: Periodontis with well defined radiolucent area PAI score 5: Severe periodontitis with elements indicating expansion of lesion
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient willing to participate in the study.
-
Age group of 15 to 40 years
-
Mature permanent mandibular molars with reversible pulpitis (positive response on the cold test and early response as compared to the adjacent or contralateral tooth)
-
Teeth exhibiting occlusal pulp exposure from primary dental caries.
-
Absence of periapical lesions assessed by radiographic examination.
-
Tooth demonstrating no mobility or swelling and no tenderness to percussion or palpation
Exclusion Criteria:
-
Primary teeth.
-
Teeth with irreversible pulpitis (spontaneous pain) or pulp necrosis, chronic periodontitis, cracked tooth, internal or external resorption, calcified canals, associated with sinus tract and furcation or apical radiolucency.
-
Immune-compromised, pregnant and patients with any systemic disorder.
-
Patients taking statin medication.
-
Failure to obtain authorization from the patient.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | PGIDS | Rohtak | Haryana | India | 124001 |
Sponsors and Collaborators
- Postgraduate Institute of Dental Sciences Rohtak
Investigators
- Principal Investigator: Sudeepender Gehlot, PGIDS, Rohtak
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Dr Sudeepender Gehlot